Toshiaki Iwase

735 citations
35 papers · 439 indexed · h-index 13
Topics
Breast Cancer Treatment Studies (12 papers)Cancer Risks and Factors (8 papers)Cancer Treatment and Pharmacology (7 papers)
Partner nations
United StatesJapanMexico

In The Last Decade

Toshiaki Iwase

33 papers receiving 438 citations

Peers

Toshiaki Iwase
Comparison fields: 5 of 59
  • Oncology 282
  • Physiology 133
  • Cancer Research 114
  • Pulmonary and Respiratory Medicine 97
  • Molecular Biology 92
Replace Riccardo Lobefaro with:
Riccardo Lobefaro Italy
A. Auriemma Italy
Anna Alyasova Russia
Ana Elisa Lohmann Canada
Utku Oflazoğlu Türkiye
Deping Zhao China
Jill K. Onesti United States
Terumasa Sowa Japan
Akihito Kazuno Japan
Tına Mistry United Kingdom
Toshiaki Iwase relative to Riccardo Lobefaro Italy Riccardo Lobefaro's profile →
Citations per field
00.5×1.5×1.8×
Riccardo Lobefaro · 1×
Citations per year

Countries citing papers authored by Toshiaki Iwase

Since Specialization
Citations

This map shows the geographic impact of Toshiaki Iwase's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toshiaki Iwase with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toshiaki Iwase more than expected).

Fields of papers citing papers by Toshiaki Iwase

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toshiaki Iwase. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toshiaki Iwase. The network helps show where Toshiaki Iwase may publish in the future.

Co-authorship network of co-authors of Toshiaki Iwase

This figure shows the co-authorship network connecting the top 25 collaborators of Toshiaki Iwase. A scholar is included among the top collaborators of Toshiaki Iwase based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toshiaki Iwase. Toshiaki Iwase is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 0
3 1
4 4
5 11
6 7
7 1
8 1
9 6
10 4
11 30
12 22
13 13
14 8
15 8
16 13
17 16
18 16
19 1
20 12

About Toshiaki Iwase

Toshiaki Iwase is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 35 papers that have together received 439 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (12 papers), Cancer Risks and Factors (8 papers) and Cancer Treatment and Pharmacology (7 papers). The work is most often cited by research in Oncology (282 citations), Cancer Research (114 citations) and Physiology (133 citations). Toshiaki Iwase has collaborated with scholars based in United States, Japan and Mexico. Frequent co-authors include Naoto T. Ueno, Takeshi Nagashima, Xiaoping Wang, Takafumi Sangai, Masahiro Sakakibara, Masaru Miyazaki, Mikhail G. Kolonin, Bora Lim, Ayako Nakagawa and Debu Tripathy. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026